Microneedle Array-Based Sensors for Diverse Applications
Legal Citation
Summary of the Inventive Concept
The invention leverages the core technology of microneedle array-based analyte monitoring to create novel sensors for various industries, including aquaculture, precision agriculture, athletic performance monitoring, pharmaceutical authentication, and environmental pollution detection.
Background and Problem Solved
The original patent focused on continuous glucose monitoring for diabetes patients. However, the limitations of this technology lie in its narrow application scope. The new inventive concept addresses this limitation by exploring the potential of microneedle array-based sensors in diverse fields, where real-time monitoring and accurate detection are crucial.
Detailed Description of the Inventive Concept
The new inventive concept comprises microneedle array-based sensors adapted for specific applications. For instance, in aquaculture, the sensor detects changes in water chemistry indicative of disease or stress in aquatic organisms. In precision agriculture, the sensor monitors nutrient levels and pH in soil, enabling optimized fertilizer application and irrigation schedules. Similarly, in athletic performance monitoring, the sensor detects changes in lactate levels, pH, and other biomarkers in sweat, providing real-time feedback to athletes. In pharmaceutical authentication, the sensor detects differences in chemical composition between authentic and counterfeit drugs. Lastly, in environmental pollution detection, the sensor detects changes in pollutant levels in air or water, triggering alerts and notifications to regulatory agencies.
Novelty and Inventive Step
The new inventive concept is novel and non-obvious in its application of microneedle array-based sensors to diverse industries, which was not contemplated in the original patent. The inventive step lies in the adaptation of the core technology to address specific problems and challenges in these new fields.
Alternative Embodiments and Variations
Alternative embodiments may include varying sensor configurations, materials, and geometries to optimize performance in specific applications. Variations may also involve integrating multiple sensors to detect a broader range of analytes or combining sensors with other technologies, such as machine learning algorithms, to enhance data analysis and decision-making.
Potential Commercial Applications and Market
The new inventive concept has significant commercial potential in various industries, including aquaculture, agriculture, sports technology, pharmaceuticals, and environmental monitoring. The target market includes companies, research institutions, and government agencies seeking innovative solutions for real-time monitoring and accurate detection in their respective fields.
CPC Classifications
| Section | Class | Group |
|---|---|---|
| A | A61 | A61B5/685 |
| A | A61 | A61B5/14514 |
| A | A61 | A61B5/14532 |
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Biomedical sensing technologies, specifically electrochemical sensors for continuous analyte monitoring, with expertise in microneedle array design, sensor signal processing, and multi-domain sensor applications
Person of Ordinary Skill (PHOSITA) Profile
A biomedical engineer or sensor design specialist with advanced degree, proficient in electrochemical sensing techniques, microelectrode fabrication, signal processing algorithms, and interdisciplinary sensor adaptation strategies
Obviousness Rationale
A PHOSITA would recognize the fundamental microneedle array sensing technology disclosed in the source patent as a versatile platform capable of adaptation across multiple domains. The core electrochemical sensing principles demonstrated in the glucose monitoring context can be readily translated to alternative analyte detection scenarios by modifying electrode coatings, signal processing algorithms, and sensor geometry. The technical foundations established in the source patent provide a clear roadmap for extending the sensing methodology to diverse monitoring applications.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,344 |
|---|---|
| Title | Fault detection for microneedle array based continuous analyte monitoring device |
| Assignee(s) | Biolinq Incorporated |